The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 5.
作者信息
Frishman William H
机构信息
Department of Cardiology and Medicine, New York Medical College, Westchester Health Care System, Valhalla, NY,
出版信息
Cardiol Rev. 2021;29(3):109. doi: 10.1097/CRD.0000000000000386.
Abstract
摘要
相似文献
1
The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 5.心血管临床试验专家的第11次试验：冠状病毒-2：第5部分。
Cardiol Rev. 2021;29(3):109. doi: 10.1097/CRD.0000000000000386.
2
Treatment of COVID-19: a review of current and prospective pharmacotherapies.治疗 COVID-19：当前和潜在药物疗法综述。
Br J Hosp Med (Lond). 2021 Mar 2;82(3):1-9. doi: 10.12968/hmed.2021.0112. Epub 2021 Mar 12.
3
Audio Interview: Covid-19 Vaccine Fundamentals.音频访谈：新冠疫苗基础知识
N Engl J Med. 2020 Dec 17;383(25):e146. doi: 10.1056/NEJMe2035370.
4
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.新型冠状病毒病 2019 患者肾功能降低或丧失的治疗选择。
Adv Chronic Kidney Dis. 2020 Sep;27(5):434-441. doi: 10.1053/j.ackd.2020.09.001. Epub 2020 Sep 17.
5
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.巴瑞替尼联合瑞德西韦治疗住院的新冠成年患者
N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.
6
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection.巴瑞替尼/瑞德西韦治疗成人 COVID-19 感染的关联观点。
Mol Biol Rep. 2022 Jan;49(1):827-831. doi: 10.1007/s11033-021-06888-8. Epub 2021 Nov 27.
7
An EUA for baricitinib (Olumiant) for COVID-19.巴瑞替尼（Olumiant）用于治疗新冠肺炎的紧急使用授权。
Med Lett Drugs Ther. 2020 Dec 28;62(1614):202-203.
8
Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19.巴瑞替尼、瑞德西韦和地塞米松联合治疗重症 COVID-19 患者的临床影响。
Respir Investig. 2021 Nov;59(6):799-803. doi: 10.1016/j.resinv.2021.07.004. Epub 2021 Aug 10.
9
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.2019冠状病毒病的抗病毒治疗：哪种最具前景？——一篇叙述性综述
Ann Palliat Med. 2021 Jan;10(1):707-720. doi: 10.21037/apm-20-1755. Epub 2021 Jan 11.
10
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.COVID-19：最新可用药物和 SARS-CoV-2 疗法综述。凝血与炎症相互作用。
Virus Res. 2020 Sep;286:198070. doi: 10.1016/j.virusres.2020.198070. Epub 2020 Jun 20.
Zotero 插件